CELLEX/XTS PHOTOPHERESIS SYSTEM: payments to doctors
Payments that named CELLEX/XTS PHOTOPHERESIS SYSTEM as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $368K
- Providers
- 92
- Transactions
- 326
- Average per transaction
- $1,129
The per-transaction average — $1,129 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 92 providers the average total is $4,001, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Mallinckrodt Enterprises LLC | $255,742 | 69.5% |
| Mallinckrodt Hospital Products Inc. | $112,355 | 30.5% |